XML 21 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Treasury stock
Retained earnings (accumulated deficit)
Accumulated other comprehensive loss
Beginning balances at Oct. 01, 2022 $ 560,512 $ 130 $ 617,390 $ (50,896) $ (2,515) $ (3,597)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans   3 17,579      
Retirement of treasury stock   (3) (62,684) 62,687    
Stock-based compensation expense     41,220      
Repurchase of common stock       (30,054)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards       (18,199)    
Net income (loss) 44,537       44,537  
Change in foreign currency translation adjustment (2,684)         (2,684)
Unrealized loss on investments 0          
Ending balances at Apr. 01, 2023 612,914 $ 130 613,505 $ (36,462) 42,022 (6,281)
Balances, beginning of period (in shares) at Oct. 01, 2022   129,823,663        
Beginning balances (in shares) at Oct. 01, 2022       (3,154,940)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans (in shares)   4,145,417        
Retirement of treasury stock (in shares)   (3,613,807)   3,613,807    
Repurchase of common stock (in shares)       (1,616,155)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards (in shares)       (928,545)    
Balances, ending of period (in shares) at Apr. 01, 2023   130,355,273        
Ending balances (in shares) at Apr. 01, 2023       (2,085,833)    
Beginning balances at Dec. 31, 2022 633,354 $ 130 606,420 $ (35,047) 72,674 (10,823)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans   1 9,478      
Retirement of treasury stock   (1) (23,418) 23,419    
Stock-based compensation expense     21,025      
Repurchase of common stock       (15,011)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards       (9,823)    
Net income (loss) (30,652)       (30,652)  
Change in foreign currency translation adjustment 4,542         4,542
Unrealized loss on investments 0          
Ending balances at Apr. 01, 2023 612,914 $ 130 613,505 $ (36,462) 42,022 (6,281)
Balances, beginning of period (in shares) at Dec. 31, 2022   129,503,753        
Beginning balances (in shares) at Dec. 31, 2022       (2,181,915)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans (in shares)   2,171,911        
Retirement of treasury stock (in shares)   (1,320,391)   1,320,391    
Repurchase of common stock (in shares)       (766,349)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards (in shares)       (457,960)    
Balances, ending of period (in shares) at Apr. 01, 2023   130,355,273        
Ending balances (in shares) at Apr. 01, 2023       (2,085,833)    
Beginning balances at Sep. 30, 2023 518,657 $ 130 607,345 $ (72,586) (12,788) (3,444)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans   4 11,901      
Retirement of treasury stock   (6) (84,437) 84,443    
Stock-based compensation expense     43,031      
Repurchase of common stock       (76,611)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards       (13,242)    
Net income (loss) 11,238       11,238  
Change in foreign currency translation adjustment (948)         (948)
Unrealized loss on investments (26)          
Ending balances at Mar. 30, 2024 $ 494,004 $ 128 577,840 $ (77,996) (1,550) (4,418)
Balances, beginning of period (in shares) at Sep. 30, 2023   130,399,940        
Beginning balances (in shares) at Sep. 30, 2023       (5,286,024)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans (in shares)   3,328,353        
Issuance of common stock pursuant to equity incentive plans (in shares) 916,779          
Retirement of treasury stock (in shares) (5,903,097) (5,903,097)   5,903,097    
Repurchase of common stock (in shares) (4,523,740)     (4,523,740)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards (in shares)       (840,735)    
Balances, ending of period (in shares) at Mar. 30, 2024   127,825,196        
Ending balances (in shares) at Mar. 30, 2024       (4,747,402)    
Beginning balances at Dec. 30, 2023 $ 594,409 $ 127 569,286 $ (38,856) 68,159 (4,307)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans   2 8,364      
Retirement of treasury stock   (1) (23,483) 23,484    
Stock-based compensation expense     23,673      
Repurchase of common stock       (53,126)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards       (9,498)    
Net income (loss) (69,709)       (69,709)  
Change in foreign currency translation adjustment (85)         (85)
Unrealized loss on investments (26)          
Ending balances at Mar. 30, 2024 $ 494,004 $ 128 $ 577,840 $ (77,996) $ (1,550) $ (4,418)
Balances, beginning of period (in shares) at Dec. 30, 2023   127,243,960        
Beginning balances (in shares) at Dec. 30, 2023       (2,672,671)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock pursuant to equity incentive plans (in shares)   2,059,833        
Retirement of treasury stock (in shares)   (1,478,597)   1,478,597    
Repurchase of common stock (in shares)       (3,045,143)    
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards (in shares)       (508,185)    
Balances, ending of period (in shares) at Mar. 30, 2024   127,825,196        
Ending balances (in shares) at Mar. 30, 2024       (4,747,402)